ScholarIQanswers from OpenAlex
University of Siena
InstitutionResearch output, impact & collaborations
University of Siena is a institution indexed in ScholarIQ from OpenAlex.
What is known about University of Siena?
ScholarIQrecord summary
University of Siena is a research organisation in Siena, IT. OpenAlex records 61,317 works and 4,868,143 citations for it. 9,237 researchers list it as their most recent affiliation.
How many works does University of Siena have?
ScholarIQindexed works
University of Siena has 61,317 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does University of Siena have?
ScholarIQcitation count
University of Siena has 4,868,143 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at University of Siena?
ScholarIQresearcher count
University of Siena has 9,237 researchers in the ScholarIQ index.
What is the average h-index at University of Siena?
ScholarIQavg h-index
University of Siena has an average h-index of 93.1 in OpenAlex.
What is the ROR of University of Siena?
ScholarIQror
The ROR for University of Siena is on the source record.
What is the OpenAlex record for University of Siena?
ScholarIQopenalex
The OpenAlex for University of Siena is on the source record.
What is the Wikidata of University of Siena?
ScholarIQwikidata
The Wikidata for University of Siena is on the source record.
Who are the most-cited researchers behind University of Siena?
ScholarIQtop researchers by citations
What are the most-cited papers on University of Siena?
ScholarIQmost cited works
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, Lily Yin Weckx, Pedro M. Folegatti, Parvinder K. Aley, Brian Angus, Vicky L. Baillie, Shaun Barnabas, Qasim Bhorat, Sagida Bibi, Carmen Briner, Paola Cicconi, Andrea M. Collins, Rachel Colin-Jones, Clare Cutland, Thomas C. Darton, Keertan Dheda, C.J. Duncan, Katherine R. W. Emary, Katie Ewer, Lee Fairlie, Saul N. Faust, Shuo Feng, Daniela M. Ferreira, Adam Finn, Anna L. Goodman, Catherine Green, Christopher Green, Paul T. Heath, Catherine Hill, Helen Hill, Ian Hirsch, Susanne H. Hodgson, Alane Izu, Susan Jackson, Daniel Jenkin, Carina C. D. Joe, Simon Kerridge, Anthonet Koen, Gaurav Kwatra, Rajeka Lazarus, Alison M. Lawrie, Alice Lelliott, Vincenzo Libri, Patrick Lillie, Raburn M. Mallory, Ana Verena Almeida Mendes, Eveline Pı́polo Milan, Angela M. Minassian, Alastair McGregor, Hazel Morrison, Yama F Mujadidi, Anusha Nana, Peter O’Reilly, Sherman D. Padayachee, Ana Maria Pittella, Emma Plested, Katrina M. Pollock, Maheshi Ramasamy, Sarah Rhead, Alexandre Vargas Schwarzbold, Nisha Singh, Darren Smith, Rinn Song, Matthew D. Snape, Eduardo Sprinz, Rebecca Sutherland, Richard Tarrant, Emma C. Thomson, M. Estée Török, Mark Toshner, David P. J. Turner, Johan Vekemans, Tonya Villafana, Marion Watson, Christopher J. Williams, Alexander D. Douglas, Adrian V. S. Hill, Teresa Lambe, Sarah C. Gilbert, Andrew J. Pollard, Marites Aban, Fatola Abayomi, Kushala W.M. Abeyskera, Jeremy Aboagye, Matthew Adam, Kirsty Adams, James P. Adamson, Yemi Adelaja, Gbadebo Adewetan, Syed Adlou, Khatija Ahmed, Yasmeen Akhalwaya, Saajida Akhalwaya, Andrew Alcock, Aabidah Ali, Elizabeth Allen, Lauren Allen, Thamires C. D. S. C Almeida
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert, L. Thomas, Igor Bondarenko, Steven O’Day, Jeffrey S. Weber, Claus Garbe, Célèste Lebbé, Jean‐François Baurain, Alessandro Testori, Jean‐Jacques Grob, Neville Davidson, Jon Richards, Michele Maio, Axel Hauschild, Wilson H. Miller, Pere Gascón, Michal Lotem, Kaan Harmankaya, Ramy Ibrahim, Stephen Francis, Tai‐Tsang Chen, Rachel Humphrey, Axel Hoos, Jedd D. Wolchok
Cerebral Blood Flow in Dementia
Vladimir Hachinski, L. D. Iliff, E. Zilhka, G. H. du Boulay, V. L. McAllister, John Marshall, R W Russell, L. Symon
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S. Weber, Sandra P. D’Angelo, David R. Minor, F. Stephen Hodi, Ralf Gutzmer, Bart Neyns, Christoph Höeller, Nikhil I. Khushalani, Wilson H. Miller, Christopher D. Lao, Gerald P. Linette, L. Thomas, Paul Lorigan, Kenneth F. Grossmann, Jessica C. Hassel, Michele Maio, Mario Sznol, Paolo A. Ascierto, Peter Mohr, Bartosz Chmielowski, Alan H. Bryce, Inge Marie Svane, Jean‐Jacques Grob, Angela M. Krackhardt, Christine E. Horak, Alexandre Lambert, Arvin Yang, James Larkin
Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)
Jean‐Pascal Lefaucheur, Nathalie André‐Obadia, Andrea Antal, Samar S. Ayache, Chris Baeken, David Benninger, Roberto Cantello, M. Cincotta, Mamede de Carvalho, Dirk De Ridder, H. Devanne, Vincenzo Di Lazzaro, Saša R. Filipović, Friedhelm C. Hummel, Satu K. Jääskeläinen, Vasilios Κ. Kimiskidis, Giacomo Koch, Berthold Langguth, Thomas Nyffeler, Antonio Oliviero, Frank Padberg, Emmanuel Poulet, Símone Rossi, Paolo Maria Rossini, John C. Rothwell, Carlos Schönfeldt‐Lecuona, Hartwig R. Siebner, Christina W. Slotema, Charlotte J. Stagg, Josep Valls‐Solé, Ulf Ziemann, Walter Paulus, Luis Garcı́a-Larrea
Who collaborates most closely around University of Siena?
ScholarIQco-authorship network
United States
67%
France
33%
MOST FREQUENT PARTNER INSTITUTIONS
How much of the research on University of Siena is open access?
ScholarIQopen access share
83%OPEN ACCESS